A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy
Clinical trial NCT00236717 · COMPLETED
Trial details
- NCT number
- NCT00236717
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1997-09-01
- Enrollment
- 865
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.